Dyspepsia Market Trends Analysis, Growth Opportunities and Challenges, Clinical Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast

August 31 13:21 2021
Dyspepsia Market Trends Analysis, Growth Opportunities and Challenges, Clinical Activities, Leading Companies, Emerging Therapies, and Epidemiology Forecast
Delveinsight Business Research LLP
DelveInsight’s “Dyspepsia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Dyspepsia Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Dyspepsia Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Dyspepsia market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Dyspepsia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

Dyspepsia Market

Dyspepsia Disease Overview

Dyspepsia is a common symptom with an extensive differential diagnosis and heterogeneous pathophysiology. This condition is very prevalent throughout the world varying with population-based estimates based on the definition used. The majority of patients with symptoms of dyspepsia are eventually categorized as having functional (idiopathic, non-ulcer) dyspepsia (FD), meaning no obvious cause for the symptoms present. FD is one of the most common gastrointestinal disorders and imposes a social and economic burden worldwide.

Dyspepsia Market Key Facts

  • As per the article by Madisch et al., 2018, FD is one of the more common functional disorders, with a prevalence of 10–20%. It affects the gastrointestinal tract.

  • According to Harer et al., (2020), the community prevalence of dyspepsia is typically quoted in the range of 20% to 40%, and the disorder accounts for 3% to 5% of primary care visits

  • According to an article by Longstreth et al., 2019 approximately 25% of patients with dyspepsia have an underlying organic cause, and nearly 75% of patients have functional (idiopathic or non-ulcer) dyspepsia with no underlying cause on diagnostic evaluation.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/dyspepsia-market

Key Benefits of Dyspepsia Market Report

  • The market report provides an in-depth analysis of Dyspepsia Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

  • The report will help in developing business strategies by understanding the Dyspepsia Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

  • The market report covers the Dyspepsia current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

  • The report provides a detailed assessment of the Dyspepsia market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Dyspepsia Market 

The Dyspepsia Market Size is anticipated to increase for the study period, 2017–2030 owing to the increase in geriatric population and changing dietary habits in the 7MM which is likely to increase the cases of FD.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Dyspepsia market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Dyspepsia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request for Sample @ Dyspepsia Therapeutics Market Assessment

Dyspepsia Epidemiology

The epidemiology section covers insights about the historical and current Dyspepsia patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Dyspepsia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Dyspepsia market or expected to get launched in the market during the study period. The analysis covers Dyspepsia market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Dyspepsia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Some of the key companies in the Dyspepsia Market include:

  • ISOThrive

  • Renexxion

  • RaQualia Pharma

  • Jiangxi Qingfeng Pharmaceutical

  • Zeria Pharmaceutical 

  • Johnson & Johnson

  • Yuhan Corporation

  • IlDong Pharmaceutical

  • Ironwood Pharmaceuticals

  • Abide Therapeutics

And others.

Dyspepsia Therapies covered in the report includes:

  • Acotiamide

  • ISOT-101

  • Naronapride

  • RQ-00000010

  • Aolanti Weipang Tablets

And many others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Dyspepsia Competitive Intelligence Analysis

4. Dyspepsia Market Overview at a Glance

5. Dyspepsia Disease Background and Overview

6. Dyspepsia Patient Journey

7. Dyspepsia Epidemiology and Patient Population

8. Dyspepsia Treatment Algorithm, Current Treatment, and Medical Practices

9. Dyspepsia Unmet Needs

10. Key Endpoints of Dyspepsia Treatment

11. Dyspepsia Marketed Products

12. Dyspepsia Emerging Therapies

13. Dyspepsia Seven Major Market Analysis

14. Attribute Analysis

15. Dyspepsia Market Outlook (7 major markets)

16. Dyspepsia Access and Reimbursement Overview

17. KOL Views on the Dyspepsia Market.

18. Dyspepsia Market Drivers

19. Dyspepsia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/dyspepsia-market

Latest Reports By DelveInsight

Dyspepsia Pipeline Insights

Dyspepsia Pipeline Insight, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Dyspepsia market.

Trending Healthcare Blog

Virtual Clinical Trials Future Outlook

The virtual clinical trial is one of the growing concepts in the healthcare sector getting significant attention owing to various benefits that they bring forth with them as compared to the conventional model. To get an early advantage and to capture the market share, tech providers such as Science 37, Syneos Health, Flatiron Health, Deep 6 AI, SubjectWell, Tempus Labs, Altos Solutions, ObvioHealth, Clinpalidor, VirTrial, Lightship, Medable, PAREXEL International, Medidata Solutions, PRA Health Sciences, Curavit, and several others are actively engaged in the virtual clinical trials segment. For more details, visit: Key Companies in Virtual Clinical Trials

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/delhi-today.com/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7